Neuropsychological assessment and cortisol levels in biofluids from early Alzheimer's disease patients

Albert, 2011, The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimers Dement., 7, 270, 10.1016/j.jalz.2011.03.008 Alegret, 2009, Detection of visuoperceptual deficits in preclinical and mild Alzheimer's disease, J. Clin. Exp. Neuropsychol., 31, 860, 10.1080/13803390802595568 Arsenault-Lapierre, 2010, Seasonal effects on cortisol secretion in normal aging, mild cognitive impairment and Alzheimer's disease, Neurobiol. Aging, 31, 1051, 10.1016/j.neurobiolaging.2008.07.011 Beheshti, 2016, Structural MRI-based detection of Alzheimer's disease using feature ranking and classification error, Comput. Methods Prog. Biomed., 137, 177, 10.1016/j.cmpb.2016.09.019 Bondi, 2008, Neuropsychological contributions to the early identification of Alzheimer's disease, Neuropsychol. Rev., 18, 73, 10.1007/s11065-008-9054-1 Cheng, 2017, Multi-domain transfer learning for early diagnosis of Alzheimer's disease, Neuroinformatics, 15, 115, 10.1007/s12021-016-9318-5 Claus, 2017, Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer's disease: validation in a large memory clinic population, Eur. Radiol., 27, 3147, 10.1007/s00330-016-4726-3 Eliassen, 2017, Convergent results from neuropsychology and from neuroimaging in patients with mild cognitive impairment, Dement. Geriatr. Cogn. Disord., 43, 144, 10.1159/000455832 Ennis, 2017, Long-term cortisol measures predict Alzheimer disease risk, Neurology, 88, 371, 10.1212/WNL.0000000000003537 García-Blanco, 2016, Reference ranges for cortisol and α-amylase in mother and newborn saliva samples at different perinatal and postnatal periods, J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 1022, 249, 10.1016/j.jchromb.2016.04.035 García-Blanco, 2018, Reliable determination of new lipid peroxidation compounds as potential early Alzheimer disease biomarkers, Talanta, 184, 193, 10.1016/j.talanta.2018.03.002 Herman, 2016, Regulation of the hypothalamic-pituitary-adrenocortical stress response, Compr. Physiol., 6, 603, 10.1002/cphy.c150015 Hoogendijk, 2006, Increased cerebrospinal fluid cortisol level in Alzheimer's disease is not related to depression, Neurobiol. Aging, 27, 780.e1, 10.1016/j.neurobiolaging.2005.07.017 Hooper, 2018, Chronically raised C-reactive protein is inversely associated with cortical β-amyloid in older adults with subjective memory complaints, Exp. Gerontol., 108, 226, 10.1016/j.exger.2018.04.014 Huang, 2009, Elevated basal cortisol level predicts lower hippocampal volume and cognitive decline in Alzheimer's disease, J. Clin. Neurosci., 16, 1283, 10.1016/j.jocn.2008.12.026 Hughes, 1982, A new clinical scale for the staging of dementia, Br. J. Psychiatry, 140, 566, 10.1192/bjp.140.6.566 Ishijima, 2018, Glucocorticoid may influence amyloid β metabolism in patients with depression, Psychiatry Res., 259, 191, 10.1016/j.psychres.2017.10.008 Jack, 2018, NIA-AA research framework: toward a biological definition of Alzheimer's disease, Alzheimers Dement., 14, 535, 10.1016/j.jalz.2018.02.018 Jang, 2018, Neuronal nitric oxide synthase is a novel biomarker for the interstitial cells of Cajal in stress-induced diarrhea-dominant irritable bowel syndrome, Dig. Dis. Sci., 63, 619, 10.1007/s10620-018-4933-7 Johnson, 2009, Longitudinal study of the transition from healthy aging to Alzheimer disease, Arch. Neurol., 66, 1254, 10.1001/archneurol.2009.158 Kronfol, 2000, Cytokines and the brain: implications for clinical psychiatry, Am. J. Psychiatry, 157, 683, 10.1176/appi.ajp.157.5.683 Laske, 2011, Identification of a blood-based biomarker panel for classification of Alzheimer's disease, Int. J. Neuropsychopharmacol., 14, 1147, 10.1017/S1461145711000459 McKhann, 2011, The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimers Dement., 7, 263, 10.1016/j.jalz.2011.03.005 Molinuevo, 2011, Neuropsychological profile of prodromal Alzheimer's disease (Prd-AD) and their radiological correlates, Arch. Gerontol. Geriatr., 52, 190, 10.1016/j.archger.2010.03.016 Molinuevo, 2014, The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's biomarkers standardization initiative, Alzheimers Dement., 10, 808, 10.1016/j.jalz.2014.03.003 Nazeri, 2014, Imaging proteomics for diagnosis, monitoring and prediction of Alzheimer's disease, Neuroimage, 2, 657, 10.1016/j.neuroimage.2014.08.041 Nicolaides, 2015, Stress, the stress system and the role of glucocorticoids, Neuroimmunomodulation, 22, 6, 10.1159/000362736 Notarianni, 2017, Cortisol: mediator of association between Alzheimer's disease and diabetes mellitus?, Psychoneuroendocrinology, 81, 129, 10.1016/j.psyneuen.2017.04.008 Palagini, 2015, Early-life origin of adult insomnia: does prenatal-early-life stress play a role?, Sleep Med., 16, 446, 10.1016/j.sleep.2014.10.013 Peña-Bautista, 2018, Plasma lipid peroxidation biomarkers for early and non-invasive Alzheimer disease detection, Free Radic. Biol. Med., 124, 388, 10.1016/j.freeradbiomed.2018.06.038 Peña-Bautista, 2019, Validated analytical method to determine new salivary lipid peroxidation compounds as potential neurodegenerative biomarkers, J. Pharm. Biomed. Anal., 164, 742, 10.1016/j.jpba.2018.11.043 Pfeffer, 1982, Measurement of functional activities in older adults in the community, J. Gerontol., 37, 323, 10.1093/geronj/37.3.323 Popp, 2015, Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type, Neurobiol. Aging, 36, 601, 10.1016/j.neurobiolaging.2014.10.031 Price, 2009, Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease, Neurobiol. Aging, 30, 1026, 10.1016/j.neurobiolaging.2009.04.002 Rami, 2007, Longitudinal study of amnesic patients at high risk for Alzheimer's disease: clinical, neuropsychological and magnetic resonance spectroscopy features, Dement. Geriatr. Cogn. Disord., 24, 402, 10.1159/000109750 Rami, 2007, Screening for amnestic mild cognitive impairment and early Alzheimer's disease with M@T (memory alteration test) in the primary care population, Int. J. Geriatr. Psychiatry, 22, 294, 10.1002/gps.1672 Randolph, 1998, The repeatable battery for the assessment of neuropsychological status (RBANS): preliminary clinical validity, J. Clin. Exp. Neuropsychol., 20, 310, 10.1076/jcen.20.3.310.823 Rasmuson, 2011, Increased serum levels of dehydroepiandrosterone (DHEA) and interleukin-6 (IL-6) in women with mild to moderate Alzheimer's disease, Int. Psychogeriatr., 23, 1386, 10.1017/S1041610211000810 Reiche, 2004, Stress, depression, the immune system, and cancer, Lancet Oncol., 5, 617, 10.1016/S1470-2045(04)01597-9 Ricci, 2012, Stress-induced cytokines and neuronal dysfunction in Alzheimer's disease, J. Alzheimers Dis., 28, 11, 10.3233/JAD-2011-110821 Sarazin, 2007, Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study, Neurology, 69, 1859, 10.1212/01.wnl.0000279336.36610.f7 Schrijvers, 2011, Associations of serum cortisol with cognitive function and dementia: the Rotterdam study, J. Alzheimers Dis., 25, 671, 10.3233/JAD-2011-110224 Souza-Talarico, 2010, Relationship between cortisol levels and memory performance may be modulated by the presence or absence of cognitive impairment: evidence from healthy elderly, mild cognitive impairment and Alzheimer's disease subjects, J. Alzheimers Dis., 19, 839, 10.3233/JAD-2010-1282 Spada, 2002, Twenty-four-hour urinary cortisol levels in Alzheimer disease and in dysthymia, Arch. Gerontol. Geriatr. Suppl., 8, 353, 10.1016/S0167-4943(02)00129-2 Toledo, 2012, Cardiovascular risk factors, cortisol, and amyloid-β deposition in Alzheimer's disease neuroimaging initiative, Alzheimers Dement., 8, 483, 10.1016/j.jalz.2011.08.008 Tortosa-Martínez, 2012, Does physical activity reduce risk for Alzheimer's disease through interaction with the stress neuroendocrine system?, Stress, 15, 243, 10.3109/10253890.2011.629323 Umegaki, 2000, Plasma cortisol levels in elderly female subjects with Alzheimer's disease: a cross-sectional and longitudinal study, Brain Res., 881, 241-24, 10.1016/S0006-8993(00)02847-X Wahlund, 2017, Imaging biomarkers of dementia: recommended visual rating scales with teaching cases, Insights Imaging, 8, 79, 10.1007/s13244-016-0521-6 Yesavage, 1982, Development and validation of a geriatric depression screening scale: a preliminary report, J. Psychiatr. Res., 17, 37, 10.1016/0022-3956(82)90033-4 Zvěřová, 2013, Plasma cortisol in Alzheimer's disease with or without depressive symptoms, Med. Sci. Monit., 19, 681, 10.12659/MSM.889110